Acetylcholine prevents angiotensin II-induced oxidative stress and apoptosis in H9c2 cells

Apoptosis

Volumn 16, Issue 1, 2011, Pages 94-103

  Liu, Jin Jun ^a   Li, Dong Ling ^a   Zhou, Juan ^a   Sun, Lei ^a   Zhao, Ming ^a   Kong, Shan Shan ^a   Wang, You Hua ^a   Yu, Xiao Jiang ^a   Zhou, Jun ^a   Zang, Wei Jin ^a  

^a XI'AN JIAOTONG UNIVERSITY   (China)

Author keywords

Acetylcholine; Angiotensin II; Apoptosis; H9c2 cells; Reactive oxygen species

Indexed keywords

ACETYLCHOLINE; ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN II; ATROPINE; CASPASE 3; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN BAX; PROTEIN BCL 2; REACTIVE OXYGEN METABOLITE; SYNAPTOPHYSIN;

ANIMAL CELL; APOPTOSIS; ARTICLE; CARDIOVASCULAR DISEASE; CELL STIMULATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; HEART MUSCLE CELL; HYPOXIA; IMMUNOBLOTTING; INHIBITION KINETICS; MOUSE; MYOBLAST; NONHUMAN; OXIDATIVE STRESS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY MECHANISM; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; UPREGULATION;

ACETYLCHOLINE; ANGIOTENSIN II; ANIMALS; APOPTOSIS; ATROPINE; BCL-2-ASSOCIATED X PROTEIN; CARDIOTONIC AGENTS; CARDIOVASCULAR DISEASES; CASPASE 3; CELLS, CULTURED; GENE EXPRESSION; MYOCYTES, CARDIAC; NADPH OXIDASE; OXIDATIVE STRESS; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-BCL-2; RATS; REACTIVE OXYGEN SPECIES; RECEPTOR, ANGIOTENSIN, TYPE 1;

EID: 79951557446     PISSN: 13608185     EISSN: 1573675X     Source Type: Journal    
DOI: 10.1007/s10495-010-0549-x     Document Type: Article

References (41)

1. VN Fedorov MM Fateev EV Sal'Nikov AV Sidorov 2009 Neurohumoral mechanisms of the rat heart adaptation to overload] Zh Evol Biokhim Fiziol 45 398 402 1:STN:280:DC%2BD1MnjsFWhtQ%3D%3D 19764636
2. H Takano H Hasegawa T Nagai I Komuro 2003 Implication of cardiac remodeling in heart failure: mechanisms and therapeutic strategies Intern Med 42 465 469 1:CAS:528:DC%2BD3sXnt1Ghsr8%3D 10.2169/internalmedicine.42.465 12857042 (Pubitemid 36926806)
3. JG Lainchbury 2001 Novel neurohumoral factors in congestive heart failure: adrenomedullin Curr Cardiol Rep 3 208 214 1:STN:280: DC%2BD3MzntVaktg%3D%3D 10.1007/s11886-001-0024-y 11305974
4. G Zhou X Li DW Hein, et al. 2008 Metallothionein suppresses angiotensin II-induced nicotinamide adenine dinucleotide phosphate oxidase activation, nitrosative stress, apoptosis, and pathological remodeling in the diabetic heart J Am Coll Cardiol 52 655 666 1:CAS:528:DC%2BD1cXpvFGgtL8%3D 10.1016/j.jacc.2008.05.019 18702970
5. J Zhou X Xu JJ Liu YX Lin GD Gao 2007 Angiotensin II receptors subtypes mediate diverse gene expression profile in adult hypertrophic cardiomyocytes Clin Exp Pharmacol Physiol 34 1191 1198 1:CAS:528:DC%2BD2sXhtFyitrzI 10.1111/j.1440-1681.2007.04570.x 17880376 (Pubitemid 46148260)
6. PK Mehta KK Griendling 2007 Angiotensin II cell signaling: physiological and pathological effects in the cardiovascular system Am J Physiol Cell Physiol 292 C82 C97 1:CAS:528:DC%2BD2sXisFCrtLc%3D 10.1152/ajpcell.00287.2006 16870827 (Pubitemid 46127306)
7. JA Byrne DJ Grieve JK Bendall, et al. 2003 Contrasting roles of NADPH oxidase isoforms in pressure-overload versus angiotensin II-induced cardiac hypertrophy Circ Res 93 802 805 1:CAS:528:DC%2BD3sXotlejs70%3D 10.1161/01.RES.0000099504.30207.F5 14551238 (Pubitemid 37363053)
8. H Nakagami M Takemoto JK Liao 2003 NADPH oxidase-derived superoxide anion mediates angiotensin II-induced cardiac hypertrophy J Mol Cell Cardiol 35 851 859 1:CAS:528:DC%2BD3sXks1artLo%3D 10.1016/S0022-2828(03)00145-7 12818576 (Pubitemid 36773597)
9. K Matsuno H Yamada K Iwata, et al. 2005 Nox1 is involved in angiotensin II-mediated hypertension: a study in Nox1-deficient mice Circulation 112 2677 2685 1:CAS:528:DC%2BD2MXhtFajtLrE 10.1161/CIRCULATIONAHA.105.573709 16246966 (Pubitemid 41532605)
10. U Landmesser H Cai S Dikalov, et al. 2002 Role of p47(phox) in vascular oxidative stress and hypertension caused by angiotensin II Hypertension 40 511 515 1:CAS:528:DC%2BD38Xntlamsrs%3D 10.1161/01.HYP.0000032100.23772.98 12364355
11. T Matsui SI Yamagishi M Takeuchi S Ueda K Fukami S Okuda 2009 Irbesartan inhibits advanced glycation end product (AGE)-induced proximal tubular cell injury in vitro by suppressing receptor for AGEs (RAGE) expression Pharmacol Res 61 1 34 39 10.1016/j.phrs.2009.07.004 19635564
12. VP Singh B Le R Khode KM Baker R Kumar 2008 Intracellular angiotensin II production in diabetic rats is correlated with cardiomyocyte apoptosis, oxidative stress, and cardiac fibrosis Diabetes 57 3297 3306 1:CAS:528:DC%2BD1MXhsleitrs%3D 10.2337/db08-0805 18829990
13. A Nakano M Kitakaze 2006 Use of angiotensin type II receptor blockers as a potential strategy for chronic heart failure Nippon Rinsho 64 910 916 16689373
14. K Makowski G Gielerak M Cholewa, et al. 2002 Autonomic nervous system and left ventricular hypertrophy in essential hypertension Kardiol Pol 57 520 531, 532 12960979
15. JF Thayer RD Lane 2007 The role of vagal function in the risk for cardiovascular disease and mortality Biol Psychol 74 224 242 10.1016/j.biopsycho.2005.11.013 17182165 (Pubitemid 46001789)
16. JS Floras 1993 Clinical aspects of sympathetic activation and parasympathetic withdrawal in heart failure J Am Coll Cardiol 22 72A 84A 1:STN:280:DyaK3szovFSitQ%3D%3D 10.1016/0735-1097(93)90466-E 8376699 (Pubitemid 23285800)
17. T Tsutsumi T Ide M Yamato, et al. 2008 Modulation of the myocardial redox state by vagal nerve stimulation after experimental myocardial infarction Cardiovasc Res 77 713 721 1:CAS:528:DC%2BD1cXjvVaisrg%3D 10.1093/cvr/cvm092 18065771 (Pubitemid 351301868)
18. MH Kim MO Kim JS Heo JS Kim HJ Han 2008 Acetylcholine inhibits long-term hypoxia-induced apoptosis by suppressing the oxidative stress-mediated MAPKs activation as well as regulation of Bcl-2, c-IAPs, and caspase-3 in mouse embryonic stem cells Apoptosis 13 295 304 10.1007/s10495-007-0160-y 18049903
19. T Kawada T Yamazaki T Akiyama, et al. 2007 Angiotensin II attenuates myocardial interstitial acetylcholine release in response to vagal stimulation Am J Physiol Heart Circ Physiol 293 H2516 H2522 1:CAS:528:DC%2BD2sXht1Wlu77L 10.1152/ajpheart.00424.2007 17644572 (Pubitemid 47605898)
20. F Qin R Patel C Yan W Liu 2006 NADPH oxidase is involved in angiotensin II-induced apoptosis in H9C2 cardiac muscle cells: effects of apocynin Free Radic Biol Med 40 236 246 1:CAS:528:DC%2BD28XksVehsA%3D%3D 10.1016/j. freeradbiomed.2005.08.010 16413406 (Pubitemid 43069349)
21. CM Werner M Bohm 2008 The therapeutic role of RAS blockade in chronic heart failure Ther Adv Cardiovasc Dis 2 167 177 10.1177/1753944708091777 19124420 (Pubitemid 351863375)
22. BJ Epstein SM Smith R Choksi 2009 Recent changes in the landscape of combination RAS blockade Expert Rev Cardiovasc Ther 7 1373 1384 1:CAS:528:DC%2BD1MXhtl2ksrvM 10.1586/erc.09.127 19900020
23. PN Seshiah DS Weber P Rocic L Valppu Y Taniyama KK Griendling 2002 Angiotensin II stimulation of NAD(P)H oxidase activity: upstream mediators Circ Res 91 406 413 1:CAS:528:DC%2BD38XntVKkt7c%3D 10.1161/01.RES.0000033523.08033.16 12215489 (Pubitemid 35034208)
24. JM Li AM Shah 2003 Mechanism of endothelial cell NADPH oxidase activation by angiotensin II. Role of the p47phox subunit J Biol Chem 278 12094 12100 1:CAS:528:DC%2BD3sXisVOnsLs%3D 10.1074/jbc.M209793200 12560337 (Pubitemid 36800187)
25. JM Li AM Shah 2004 Endothelial cell superoxide generation: regulation and relevance for cardiovascular pathophysiology Am J Physiol Regul Integr Comp Physiol 287 R1014 R1030 1:CAS:528:DC%2BD2cXhtVaqt7%2FJ 15475499
26. L Gao W Wang YL Li, et al. 2005 Sympathoexcitation by central ANG II: roles for AT1 receptor upregulation and NAD(P)H oxidase in RVLM Am J Physiol Heart Circ Physiol 288 H2271 H2279 1:CAS:528:DC%2BD2MXktlShtLg%3D 10.1152/ajpheart.00949.2004 15637113 (Pubitemid 40604115)
27. RM Touyz X Chen F Tabet, et al. 2002 Expression of a functionally active gp91phox-containing neutrophil-type NAD(P)H oxidase in smooth muscle cells from human resistance arteries: regulation by angiotensin II Circ Res 90 1205 1213 1:CAS:528:DC%2BD38XkvV2gsb8%3D 10.1161/01.RES.0000020404.01971.2F 12065324 (Pubitemid 34786906)
28. R Choudhary KM Baker J Pan 2008 All-trans retinoic acid prevents angiotensin II- and mechanical stretch-induced reactive oxygen species generation and cardiomyocyte apoptosis J Cell Physiol 215 172 181 1:CAS:528:DC%2BD1cXjt1CgsL0%3D 10.1002/jcp.21297 17941088 (Pubitemid 351363202)
29. CF Mueller MU Becher S Zimmer S Wassmann B Keuler G Nickenig 2010 Angiotensin II triggers release of leukotriene C(4) in vascular smooth muscle cells via the multidrug resistance-related protein 1 Mol Cell Biochem 333 1-2 261 267 1:CAS:528:DC%2BD1MXhsFKns7fN 10.1007/s11010-009-0227-x 19685171
30. S Kimura GX Zhang A Nishiyama, et al. 2005 Role of NAD(P)H oxidase- and mitochondria-derived reactive oxygen species in cardioprotection of ischemic reperfusion injury by angiotensin II Hypertension 45 860 866 1:CAS:528:DC%2BD2MXjtlylsrw%3D 10.1161/01.HYP.0000163462.98381.7f 15824196 (Pubitemid 40628929)
31. T Kawada T Yamazaki T Akiyama, et al. 2008 Vagal stimulation suppresses ischemia-induced myocardial interstitial myoglobin release Life Sci 83 490 495 1:CAS:528:DC%2BD1cXhtFekt7jF 10.1016/j.lfs.2008.07.013 18713640
32. K Uemura M Li T Tsutsumi, et al. 2007 Efferent vagal nerve stimulation induces tissue inhibitor of metalloproteinase-1 in myocardial ischemia-reperfusion injury in rabbit Am J Physiol Heart Circ Physiol 293 H2254 H2261 1:CAS:528:DC%2BD2sXht1WlurnL 10.1152/ajpheart.00490.2007 17693545 (Pubitemid 47605869)
33. Q Qin JM Downey MV Cohen 2003 Acetylcholine but not adenosine triggers preconditioning through PI 3-kinase and a tyrosine kinase Am J Physiol Heart Circ Physiol 284 H727 H734 12388236
34. PB Corr RA Gillis 1974 Role of the vagus nerves in the cardiovascular changes induced by coronary occlusion Circulation 49 86 97 1:STN:280: DyaE2c%2Fls1ymtw%3D%3D 4808850
35. M Ando RG Katare Y Kakinuma, et al. 2005 Efferent vagal nerve stimulation protects heart against ischemia-induced arrhythmias by preserving connexin43 protein Circulation 112 164 170 1:CAS:528:DC%2BD2MXlvVSnsL4%3D 10.1161/CIRCULATIONAHA.104.525493 15998674 (Pubitemid 40982297)
36. E Vanoli GM De Ferrari M Stramba-Badiale SJ Hull RD Foreman PJ Schwartz 1991 Vagal stimulation and prevention of sudden death in conscious dogs with a healed myocardial infarction Circ Res 68 1471 1481 1:STN:280: DyaK3M3gvVOgug%3D%3D 2019002
37. GM De Ferrari A Mazzuero L Agnesina, et al. 2008 Favourable effects of heart rate reduction with intravenous administration of ivabradine in patients with advanced heart failure Eur J Heart Fail 10 550 555 10.1016/j.ejheart.2008. 04.005 18486549
38. JA Joseph DR Fisher A Carey A Szprengiel 2004 The M3 muscarinic receptor i3 domain confers oxidative stress protection on calcium regulation in transfected COS-7 cells Aging Cell 3 263 271 1:CAS:528:DC%2BD2cXos1ymtLc%3D 10.1111/j.1474-9728.2004.00123.x 15379850 (Pubitemid 40246695)
39. B Yang H Lin C Xu, et al. 2005 Choline produces cytoprotective effects against ischemic myocardial injuries: evidence for the role of cardiac m3 subtype muscarinic acetylcholine receptors Cell Physiol Biochem 16 163 174 1:CAS:528:DC%2BD2MXht1agsbfP 10.1159/000089842 16301817 (Pubitemid 41643017)
40. PJ Schwartz E Vanoli L Crotti, et al. 2008 Neural control of heart rate is an arrhythmia risk modifier in long QT syndrome J Am Coll Cardiol 51 920 929 10.1016/j.jacc.2007.09.069 18308161 (Pubitemid 351282460)
41. NP Mel'nikova SS Timoshin EY Jivotova LJ Pelliniemi E Jokinen E Abdelwahid 2006 Angiotensin-II activates apoptosis, proliferation and protein synthesis in the left heart ventricle of newborn albino rats Int J Cardiol 112 219 222 10.1016/j.ijcard.2005.09.003 16297473 (Pubitemid 44353796)